These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29294465)

  • 61. Hyperprolactinemia after treatment of long-acting gonadotropin-releasing hormone analogue Decapeptyl in girls with central precocious puberty.
    Kauschansky A; Nussinovitch M; Frydman M; Yeshaya A; Ben-Rafael Z
    Fertil Steril; 1995 Aug; 64(2):285-7. PubMed ID: 7615104
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J; Reynaud R; Czernichow P
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Changes in growth hormone-binding protein in girls with central precocious puberty treated with a depot preparation of luteinizing hormone-releasing hormone analogue.
    Oliveira SB; Donnadieu M; Chaussain JL
    Horm Res; 1993; 39(1-2):42-6. PubMed ID: 8406338
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Deslorelin. D-Trp-LHRH-PEA, LHRH agonist analogue, Somagard.
    Drugs R D; 1999 Dec; 2(6):420-2. PubMed ID: 10763456
    [No Abstract]   [Full Text] [Related]  

  • 65. Familial male-limited precocious puberty (testotoxicosis): Usefulness of treatment with ketoconazole and triptorelin.
    García García E; Álvarez Del Vayo C; Castaño L
    Med Clin (Barc); 2022 Dec; 159(11):e79-e80. PubMed ID: 36049976
    [No Abstract]   [Full Text] [Related]  

  • 66. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty.
    Tung YC; Lee JS; Tsai WY; Hsiao PH
    J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Triptorelin embonate: a 6-month formulation for prostate cancer.
    Whelan P
    Expert Opin Pharmacother; 2010 Dec; 11(17):2929-32. PubMed ID: 20969451
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Precocious puberty secondary to tuberculous meningitis].
    Buño Soto M; Muñoz Calvo MT; Seijas Martínez-Echevarría L; Pozo Román J; Argente Oliver J
    An Esp Pediatr; 1998 Dec; 49(6):635-7. PubMed ID: 9972630
    [No Abstract]   [Full Text] [Related]  

  • 69. Assessment of Estradiol Response after Depot Triptorelin Administration in Girls with Central Precocious Puberty.
    Freire AV; Gryngarten MG; Ballerini MG; Arcari AJ; Escobar ME; Bergadá I; Ropelato MG
    Horm Res Paediatr; 2016; 85(1):58-64. PubMed ID: 26675317
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Postponement of canine puberty by neonatal administration of a long term release GnRH superagonist.
    Faya M; Marchetti C; Priotto M; Grisolía M; D'Francisco F; Gobello C
    Theriogenology; 2018 Sep; 118():190-195. PubMed ID: 29913424
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fertility of Women Treated during Childhood with Triptorelin (Depot Formulation) for Central Precocious Puberty: The PREFER Study.
    Martinerie L; de Mouzon J; Blumberg J; di Nicola L; Maisonobe P; Carel JC;
    Horm Res Paediatr; 2020; 93(9-10):529-538. PubMed ID: 33774631
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature.
    Kocova M; Kochova E; Sukarova-Angelovska E
    BMC Endocr Disord; 2015 Dec; 15():82. PubMed ID: 26666878
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Long-term therapy of true precocious puberty in girls using Decapetyl-Depot, a superactive gonadoliberin agonist in depot microcapsulated form].
    Sippell WG; Partsch CJ; Hümmelink R; Lorenzen F
    Cesk Pediatr; 1994; 49(1):13-8. PubMed ID: 8124743
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.
    Heger S; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4583-90. PubMed ID: 10599723
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.
    Roth CL; Brendel L; Rückert C; Hartmann K
    Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Local reactions to luteinizing hormone releasing hormone analog therapy.
    Tonini G; Marinoni S; Forleo V; Rustico M
    J Pediatr; 1995 Jan; 126(1):159-60. PubMed ID: 7815213
    [No Abstract]   [Full Text] [Related]  

  • 77. Management of Systemic Hypersensitivity Reactions to Gonadotropin-Releasing Hormone Analogues during Treatment of Central Precocious Puberty.
    Kirkgoz T; Karakoc-Aydiner E; Bugrul F; Yavas Abali Z; Helvacioglu D; Kiykim A; Bilgic Eltan S; Aruci Kasap N; Baris S; Ozen A; Guran T; Bereket A; Turan S
    Horm Res Paediatr; 2020; 93(1):66-72. PubMed ID: 31972562
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum inhibin A and inhibin B in central precocious puberty before and during treatment with GnRH agonists.
    Sehested A; Andersson AM; Müller J; Skakkebaek NE
    Horm Res; 2000; 54(2):84-91. PubMed ID: 11251372
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Precocious puberty.
    Neely EK; Crossen SS
    Curr Opin Obstet Gynecol; 2014 Oct; 26(5):332-8. PubMed ID: 25144596
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.
    Magiakou MA; Manousaki D; Papadaki M; Hadjidakis D; Levidou G; Vakaki M; Papaefstathiou A; Lalioti N; Kanaka-Gantenbein C; Piaditis G; Chrousos GP; Dacou-Voutetakis C
    J Clin Endocrinol Metab; 2010 Jan; 95(1):109-17. PubMed ID: 19897682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.